Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 5;10(1):2153644.
doi: 10.1080/20018525.2022.2153644. eCollection 2023.

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study

Affiliations

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study

Charlotte Sandau et al. Eur Clin Respir J. .

Abstract

Objectives: For patients admitted with an acute exacerbation of COPD (AECOPD) and a need for supplementary oxygen therapy, to determine if peripheral oxygen saturation < 88% (hypoxemia) or >92% (hyperoxemia), within first 24 hours of admission, is associated with 'treatment failure' or fewer days alive and out of hospital within 14 days after admission.

Design: A retrospective multicenter observational study, reviewing consecutive data on SpO2, oxygen, and drug administration at three predefined time points, on adverse events in patients admitted with COPD between December 2019 and June 2020. Multivariable logistic regression analysis, Mann Whitney U- and Chi-square-test were used.

Setting: Acute hospital setting, across four different hospitals in the capital region of Denmark.

Participants: Patients with a confirmed diagnosis of COPD admitted with an acute exacerbation and an oxygen need within the first 24 hours admission.

Results: In total 289 COPD patients were included. The median age was 74.8 years [interquartile range (IQR):69.6 to 81.8], 191 were female and 132 patients experienced 'treatment failure'. A minimum of one episode of hypoxemia (SpO2 < 88%) within first 24 hours was associated with having a low number (≤4) of days alive and out of hospital within 14 days after admission: OR 2.4 (95%CI 1.2 to 4.8), p = 0.02, absolute risk 44% vs. 26% p = 0.01, Chi-square. Comparable results were observed after 30 days of follow-up: OR 2.6 (95% CI 1.0 to7.1), p = 0.05. A minimum of one measurement of hyperoxemia (SpO2 > 92%), within first 24 hours of admission was not associated with low number of days alive and out of hospital within 14 days OR 1.0 (95% CI 0.5 to 2.1) nor at 30 days.

Conclusion: For admitted patients with AECOPD, being hypoxemic ever within the first 24 hours after admission is associated with a substantially increased risk of a poor prognosis.

Keywords: AECOPD; Hypoxemia; admission; hyperoxemia; late respiratory failure; oxygen therapy; treatment failure.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Shows patient flow from screening, to inclusion and through first 24 hours treatment and into Days Alive and Out of Hospital up until 30 days from admission (DAOH-30). The flowchart illustrates the composites of ‘Treatment failure’ and ‘late hypercapnic respiratory failure’ by showing a) the number of events within first 24 hours of treatment, B) number of events after 24 hours of treatment given by numbers (%); ‘treatment failure’ 132 (45.6%) and ‘late hypercapnic respiratory failure’ 28(9%) and C) total number of events.
Figure 2.
Figure 2.
Forest plot showing risks of exposures as Odds Ratios [95% Confindence Intervals] in relation to low numbers of days alive and out of hospital within 14 days and treatment failure.

Similar articles

Cited by

References

    1. Pauwels RA, Rabe KF.. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(Aug 14):4–9. - PubMed
    1. Murray SA, Kendall M, Boyd K, et al. Clinical review Illness trajectories and palliative care. Lancet. 1997. may;24:1007–1011. - PMC - PubMed
    1. Decramer M, Janssens W.Chronic obstructive pulmonary disease and comorbidities.Lancet Respir [Internet]. 2021;1(1):73–83. - PubMed
    1. Chronic-obstructive-pulmonary-disease-(COPD) [Internet]. World Health Organization . 2020. Oct 24. [cited 2020 Oct 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...)
    1. Andreassen H, Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J. 2003;22(Supplement 46):2s–4s. - PubMed

LinkOut - more resources